STOCK TITAN

CGNX (NASDAQ: CGNX) discloses option‑linked sales and $7.4M reported proceeds

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CGNX reported proposed sales of common stock under Rule 144 and disclosed recent dispositions. The notice lists intended sales of 6,100, 10,000 and 25,500 shares tied to option grants, and two completed dispositions in the past three months of 14,881 shares for $850,554.00 and 98,122 shares for $6,554,765.00.

The filing identifies the transactions as issuer-related option exercises and records the broker as Robert W Baird & Co on 05/12/2026. Timing and cash‑flow treatment for the planned sales are shown as 05/12/2026.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice of planned issuer-related dispositions and recent sales.

The filing lists planned sales of vested option shares (6,100; 10,000; 25,500) and reports two recent dispositions: 14,881 shares for $850,554.00 and 98,122 shares for $6,554,765.00. The broker is identified as Robert W Baird & Co.

These entries are procedural disclosures under Rule 144; cashflow treatment and any resale mechanics are tied to the option grants and the broker instructions shown. Subsequent filings would show settlement details if relevant.

Planned sale (option granted 2/21/2023) 6,100 shares intended sale date 05/12/2026
Planned sale (option granted 5/1/2019) 10,000 shares intended sale date 05/12/2026
Planned sale (option granted 2/18/2020) 25,500 shares intended sale date 05/12/2026
Sale reported 02/12/2026 14,881 shares proceeds <money>$850,554.00</money>
Sale reported 05/11/2026 98,122 shares proceeds <money>$6,554,765.00</money>
Broker Robert W Baird & Co listed in securities to be sold section dated 05/12/2026
Rule 144 regulatory
"144: Securities Sold During The Past 3 Months"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Option Granted financial
"Option Granted 2/21/2023; Option Granted 5/1/2019; Option Granted 2/18/2020"
Broker‑dealer market
"Robert W Baird & Co 777 East Wisconsin Avenue Milwaukee WI 53202"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What sales does the CGNX Form 144 disclose?

The filing lists planned sales of 6,100, 10,000 and 25,500 common shares tied to option grants. It also records two past dispositions of 14,881 and 98,122 shares.

How much proceeds were reported for recent CGNX dispositions?

The notice shows proceeds of $850,554.00 for a sale of 14,881 shares and $6,554,765.00 for a sale of 98,122 shares in the past three months.

Which broker is listed on the CGNX Form 144?

The broker-dealer listed is Robert W Baird & Co, with the address shown as 777 East Wisconsin Avenue, Milwaukee, WI. The broker appears on the 05/12/2026 entries.

Are the planned CGNX sales tied to option grants?

Yes. The filing explicitly links the planned sales to option grants dated 2/21/2023, 5/1/2019, and 2/18/2020, with the intended sale date shown as 05/12/2026.